(Q38441450)

English

Dissection of immune gene networks in primary melanoma tumors critical for antitumor surveillance of patients with stage II-III resectable disease

scientific article published on 12 February 2014

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Dissection of immune gene networks in primary melanoma tumors critical for antitumor surveillance of patients with stage II-III resectable disease (English)

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Jacques Banchereau

22

object named as

Jacques Banchereau

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Damien Chaussabel

object named as

Damien Chaussabel

23

0 references

object named as

Yichun Fu

10

0 references

Steven J. Burakoff

27

object named as

Steven J Burakoff

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Jedd D. Wolchok

25

object named as

Jedd D Wolchok

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

30

object named as

Miriam Merad

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

31

object named as

Eric E Schadt

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

26

object named as

Nina Bhardwaj

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

author name string

Shanthi Sivendran

1

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Rui Chang

2

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Lisa Pham

3

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Robert G Phelps

4

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Sara T Harcharik

5

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Lawrence D Hall

6

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Sebastian G Bernardo

7

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Marina M Moskalenko

8

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Meera Sivendran

9

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Ellen H de Moll

11

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Michael Pan

12

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Jee Young Moon

13

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Sonali Arora

14

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Ariella Cohain

15

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Analisa DiFeo

16

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Tammie C Ferringer

17

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Mikhail Tismenetsky

18

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Cindy L Tsui

19

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Philip A Friedlander

20

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Michael K Parides

21

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Mark G Lebwohl

24

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

William K Oh

28

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Karolina Palucka

29

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Yvonne M Saenger

32

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

language of work or name

0 references

publication date

12 February 2014

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Journal of Investigative Dermatology

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

134

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

8

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

2202-2211

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291112

6 September 2017

Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291112

6 September 2017

Implementing genomic medicine in the clinic: the future is here

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291112

6 September 2017

Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291112

6 September 2017

Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291112

6 September 2017

Molecular profiling reveals low- and high-grade forms of primary melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291112

6 September 2017

The prognostic impact of anti-cancer immune response: a novel classification of cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291112

6 September 2017

Immune infiltration in human cancer: prognostic significance and disease control

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291112

6 September 2017

Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291112

6 September 2017

Final version of 2009 AJCC melanoma staging and classification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291112

6 September 2017

Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291112

6 September 2017

Direct multiplexed measurement of gene expression with color-coded probe pairs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291112

6 September 2017

Sentinel-node biopsy or nodal observation in melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291112

6 September 2017

Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291112

6 September 2017

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291112

6 September 2017

Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291112

27 September 2017

The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291112

31 August 2018

BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291112

31 August 2018

Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291112

31 August 2018

Digital mRNA profiling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291112

31 August 2018

Histologic classification of tumor-infiltrating lymphocytes in primary cutaneous malignant melanoma. A study of interobserver agreement.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291112

31 August 2018

What can stochastic resonance do?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24522433

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24522433

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CCR5 is characteristic of Th1 lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2014.85

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/JID.2014.85

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38441450&oldid=2201712054"